Po‐Ju Lin

648 total citations
22 papers, 494 citations indexed

About

Po‐Ju Lin is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, Po‐Ju Lin has authored 22 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Otorhinolaryngology and 7 papers in Oncology. Recurrent topics in Po‐Ju Lin's work include Head and Neck Cancer Studies (11 papers), Head and Neck Surgical Oncology (6 papers) and Viral-associated cancers and disorders (4 papers). Po‐Ju Lin is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Head and Neck Surgical Oncology (6 papers) and Viral-associated cancers and disorders (4 papers). Po‐Ju Lin collaborates with scholars based in Taiwan, China and United Kingdom. Po‐Ju Lin's co-authors include Yi‐Chun Liu, Chih‐Wen Twu, Jin‐Ching Lin, Rong‐San Jiang, Wenyi Wang, Kai-Li Liang, Kai‐Li Liang, Shu‐Chu Shiesh, Chiung-Yu Chen and Wei-Lun Tsai and has published in prestigious journals such as Cancer, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Po‐Ju Lin

20 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Ju Lin Taiwan 11 239 204 203 121 82 22 494
Ping‐Tsung Chen Taiwan 14 54 0.2× 120 0.6× 201 1.0× 59 0.5× 69 0.8× 35 436
F. Rolland France 11 135 0.6× 92 0.5× 230 1.1× 41 0.3× 99 1.2× 29 457
Özden Altundağ Türkiye 12 76 0.3× 146 0.7× 158 0.8× 41 0.3× 69 0.8× 50 405
Daniel U. Riihimaki United States 12 104 0.4× 289 1.4× 331 1.6× 78 0.6× 29 0.4× 14 611
Jere T. W. Licciardello United States 7 128 0.5× 127 0.6× 194 1.0× 24 0.2× 66 0.8× 8 463
Antonio Rueda‐Domínguez Spain 13 35 0.1× 75 0.4× 206 1.0× 105 0.9× 99 1.2× 49 490
Francesca Arcadipane Italy 18 98 0.4× 366 1.8× 227 1.1× 35 0.3× 26 0.3× 47 618
CC Yau China 11 395 1.7× 357 1.8× 474 2.3× 42 0.3× 71 0.9× 30 980
Eun Ji Han South Korea 12 48 0.2× 129 0.6× 78 0.4× 35 0.3× 36 0.4× 46 425
Hakan Karagöl Türkiye 12 53 0.2× 133 0.7× 178 0.9× 28 0.2× 52 0.6× 35 489

Countries citing papers authored by Po‐Ju Lin

Since Specialization
Citations

This map shows the geographic impact of Po‐Ju Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Ju Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Ju Lin more than expected).

Fields of papers citing papers by Po‐Ju Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Ju Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Ju Lin. The network helps show where Po‐Ju Lin may publish in the future.

Co-authorship network of co-authors of Po‐Ju Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Ju Lin. A scholar is included among the top collaborators of Po‐Ju Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Ju Lin. Po‐Ju Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Twu, Chih‐Wen, Po‐Ju Lin, Yi‐Chun Liu, et al.. (2025). Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact. Oral Oncology. 167. 107456–107456.
2.
Zong, Jing, Po‐Ju Lin, Hsiao‐Hui Tsou, et al.. (2023). Comparison the acute toxicity of two different induction chemotherapy schedules with cisplatin and fluorouracil in nasopharyngeal carcinoma patients. Radiotherapy and Oncology. 184. 109699–109699. 2 indexed citations
3.
Meeson, Annette, Chuan-Chih Hsu, Chien‐Chung Chen, et al.. (2022). Porous scaffold for mesenchymal cell encapsulation and exosome-based therapy of ischemic diseases. Journal of Controlled Release. 352. 879–892. 24 indexed citations
4.
Twu, Chih‐Wen, Po‐Ju Lin, Hsiao‐Hui Tsou, et al.. (2022). Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma. Head & Neck. 44(6). 1453–1461. 6 indexed citations
5.
Lin, Hsuan-Yu, Sheng‐Hung Wang, Po‐Ju Lin, et al.. (2021). Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy. Scientific Reports. 11(1). 6644–6644. 6 indexed citations
7.
Lan, Ming‐Ying, Hsiao‐Hui Tsou, Chih‐Wen Twu, et al.. (2020). Survival impacts of different nodal characteristics and T-classification in N3 nasopharyngeal carcinoma patients. Oral Oncology. 108. 104820–104820. 9 indexed citations
8.
Chen, Chen-Yun, Jianhua Zhang, Jen-Hao Lin, et al.. (2019). Hypoxia-induced H19/YB-1 cascade modulates cardiac remodeling after infarction. Theranostics. 9(22). 6550–6567. 60 indexed citations
9.
Liu, Yi‐Chun, Wenyi Wang, Chih‐Wen Twu, et al.. (2018). Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma. Scientific Reports. 8(1). 470–470. 10 indexed citations
12.
Lee, Chen‐Yi, et al.. (2017). Betel Nut Chewing Is Associated With Reduced Tacrolimus Concentration in Taiwanese Liver Transplant Recipients. Transplantation Proceedings. 49(2). 326–329. 5 indexed citations
13.
Liu, Yi‐Chun, Wenyi Wang, Chih‐Wen Twu, et al.. (2016). Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients. Oral Oncology. 64. 15–21. 42 indexed citations
14.
Lin, Po‐Ju, et al.. (2015). Predictors of Biliary Leakage After T-Tube Removal in Living Donor Liver Transplantation Recipients. Transplantation Proceedings. 47(8). 2488–2492. 2 indexed citations
15.
Twu, Chih‐Wen, Wenyi Wang, Kai-Li Liang, et al.. (2014). Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid. International Journal of Radiation Oncology*Biology*Physics. 89(1). 21–29. 79 indexed citations
16.
Lin, Po‐Ju, et al.. (2013). Liver Transplantation in Patients Infected With Gram-Negative Bacteria: Non–Acinetobacter baumannii and Acinetobacter baumannii. Transplantation Proceedings. 45(1). 225–230. 5 indexed citations
17.
Chen, Chiung-Yu, et al.. (2012). Glycine ameliorates liver injury and vitamin D deficiency induced by bile duct ligation. Clinica Chimica Acta. 420. 150–154. 18 indexed citations
18.
Twu, Chih‐Wen, Rong‐San Jiang, Kai‐Li Liang, et al.. (2012). Long‐term survival analysis of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA levels. Cancer. 119(5). 963–970. 121 indexed citations
19.
Chen, Chiung-Yu, Wei-Lun Tsai, Po‐Ju Lin, & Shu‐Chu Shiesh. (2011). The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease. Clinical Chemistry and Laboratory Medicine (CCLM). 49(11). 1817–21. 38 indexed citations
20.
Lin, Po‐Ju, et al.. (2011). Extracorporeal Membrane Oxygenation Support in Potential Organ Donors for Brain Death Determination. Transplantation Proceedings. 43(7). 2495–2498. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026